A thermostable mRNA vaccine against COVID-19

Zhang, Na-Na, Li, Xiao-Feng, Deng, Yong-Qiang, Zhao, Hui, Huang, Yi-Jiao, Yang, Guan, Huang, Wei-Jin, Gao, Peng +23 more·2020·Cell
DOI 10.1016/j.cell.2020.07.024

Cited by (670)

Items 201–300 of 670

  1. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity
    Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary, Anurag Maurya, Nimita Kant, Osamah Al Rugaie, Hoineiting Rebecca Haokip, Deepika Yadav, Rakesh Roshan, Ramasare Prasad et al. · 2021 · Cells
  2. Engineered mRNA Delivery Systems for Biomedical Applications
    Ji Wang, Haofang Zhu, Jingjing Gan, Gaofeng Liang, Ling Li, Yuanjin Zhao · 2023 · Advanced Materials
  3. Advances in vaccine delivery systems against viral infectious diseases
    Dongyoon Kim, Yina Wu, Young Bong Kim, Yu‐Kyoung Oh · 2021 · Drug Delivery and Translational Research
  4. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
    Cory James Knudson, Pedro Alves-Peixoto, Hiromi Muramatsu, Colby Stotesbury, Lingjuan Tang, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Norbert Pardi, Luis J. Sigal · 2021 · Molecular Therapy
  5. Advanced Materials for SARS‐CoV‐2 Vaccines
    Moustafa T. Mabrouk, Wei‐Chiao Huang, Luis Martínez‐Sobrido, Jonathan F. Lovell · 2021 · Advanced Materials
  6. A novel mRNA vaccine, SYS6006, against SARS-CoV-2
    Ke Xu, Wenwen Lei, Bin Kang, Hanyu Yang, Yajuan Wang, Yanli Lu, Lu Lv, Yufei Sun, Jing Zhang, Xiaolin Wang et al. · 2023 · Frontiers in Immunology
  7. Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
    Zhimin Ma, Zhengyun Huang, Chi Zhang, Xiangpeng Liu, Jie Zhang, Hui Shu, Yue Ma, Zhiwei Liu, Yu Ying Feng, Xiyue Chen et al. · 2022 · Diabetologia
  8. Classification of five SARS-CoV-2 serotypes based on RBD antigenicities
    Shixiong Hu, Chunli Wu, Xinkai Wu, Xuehui Ma, Chang Shu, Qian Chen, Anqi Zheng, Huiting Yang, Jian Lü, Pei Du et al. · 2023 · 中国科学通报：英文版
  9. The potential of mRNA vaccines in cancer nanomedicine and immunotherapy
    Shulin Pan, Rangrang Fan, Bo Ram Han, Aiping Tong, Gang Feng Guo · 2023 · Trends in Immunology
  10. Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain
    Qingqing Feng, Keman Cheng, Lizhuo Zhang, Dongshu Wang, Xiaoyu Gao, Jie Liang, Guangna Liu, Nana Ma, Xu Chen, Ming Tang et al. · 2024 · Nature Communications
  11. A Systematic Review of Advanced Drug Delivery Systems: Engineering Strategies, Barrier Penetration, and Clinical Progress (2016–April 2025)
    Assem Uzakova, Elmira M. Yergaliyeva, Azamat Yerlanuly, Mukatayeva Zhazira Sagatbekovna · 2025 · Pharmaceutics
  12. Secreted Expression of mRNA‐Encoded Truncated ACE2 Variants for SARS‐CoV‐2 via Lipid‐Like Nanoassemblies
    Min Li, Sanpeng Li, Yixuan Huang, Haixia Chen, Songya Zhang, Zhicheng Zhang, Weigang Wu, Xiaobin Zeng, Boping Zhou, Bin Li · 2021 · Advanced Materials
  13. Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives
    Ivana Jarak, Miguel Pereira‐Silva, Ana Cláudia Paiva‐Santos, Francisco Veiga, Horacio Cabral, Ana Figueiras · 2021 · Applied Materials Today
  14. Electroporation in Clinical Applications—The Potential of Gene Electrotransfer and Electrochemotherapy
    Katarzyna Rakoczy, Monika Kisielewska, Mikołaj Sędzik, Laura Jonderko, Julia Celińska, Natalia Julia Sauer, Wojciech Szlasa, Jolanta Saczko, Vitalij Novickij, Julita Kulbacka · 2022 · Applied Sciences
  15. Bioinspired cellular membrane-derived vesicles for mRNA delivery
    Xiaomin Xu, Limei Xu, Jingzhi Wang, Caining Wen, Jiang Xia, Yuanmin Zhang, Yujie Liang · 2024 · Theranostics
  16. Characterization of mRNA-LNP structural features and mechanisms for enhanced mRNA vaccine immunogenicity
    Kangzeng Wu, Fengwei Xu, Yongchao Dai, Shanshan Jin, Anjie Zheng, Ning Zhang, Yuhong Xu · 2024 · Journal of Controlled Release
  17. Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
    L. Karpenko, A. P. Rudometov, S. V. Sharabrin, D. Shcherbakov, M. B. Borgoyakova, S. Bazhan, E. Volosnikova, N. Rudometova, L. A. Orlova, I. Pyshnaya et al. · 2021 · Vaccines
  18. Quantitative Assessment of the Physical Virus Titer and Purity by Ultrasensitive Flow Virometry
    Qian Niu, Ling Ma, Shaobin Zhu, Lan Li, Qisheng Zheng, Jibo Hou, Hong Lian, Lina Wu, Xiaomei Yan · 2021 · Angewandte Chemie International Edition
  19. Nanotechnology for the management of COVID-19 during the pandemic and in the post-pandemic era
    Chun Xu, Chang Lei, Sepanta Hosseinpour, Sašo Ivanovski, Laurence James Walsh, Ali Khademhosseini · 2022 · National Science Review
  20. Viral vector and nucleic acid vaccines against COVID-19: A narrative review
    Saeed Khoshnood, Roya Ghanavati, Maryam Shirani, Hossein Ghahramanpour, Mohammad Sholeh, Aref Shariati, Nourkhoda Sadeghifard, Mohsen Heidary · 2022 · Frontiers in Microbiology
  21. Immune Response to SARS-CoV-2 Vaccines
    Navya Bellamkonda, Upendra Pradeep Lambe, Sonali Ankush Sawant, Shyam Sundar Nandi, Chiranjib Chakraborty, Deepak Shukla · 2022 · Biomedicines
  22. Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out
    Anindita De, Young Tag Ko · 2023 · Expert Opinion on Drug Delivery
  23. Sniping Cancer Stem Cells with Nanomaterials
    Wen-Da Wang, Yanyu Guo, Zhonglu Yang, Guang-Liang Su, Zhi‐Jun Sun · 2023 · ACS Nano
  24. Recent Insights into Emerging Coronavirus: SARS-CoV-2
    Zifang Shang, Siew Yin Chan, William J. Liu, Peng Li, Wei Huang · 2020 · ACS Infectious Diseases
  25. Microfluidic ultrasonic cavitation enables versatile and scalable synthesis of monodisperse nanoparticles for biomedical application
    Zhikai Liu, Mei Yang, Yao Wang, Tingting Wang, Guangwen Chen · 2023 · Chemical Engineering Science
  26. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules
    Jingjing Zhang, Yuheng Liu, Chao Li, Qin Xiao, Dandan Zhang, Yang Chen, Joseph Rosenecker, Xiaoyan Ding, Shan Guan · 2023 · Pharmaceutics
  27. Engineered bacteria as an orally administered anti-viral treatment and immunization system
    Nitin S. Kamble, Shindu C. Thomas, Tushar Madaan, Nadia Ehsani, Saqib Sange, Kiersten Tucker, Alexis Muhumure, Sarah Kunkler, Nalinikanth Kotagiri · 2025 · Gut Microbes
  28. mRNA delivery via non-viral carriers for biomedical applications
    Qi Shuai, Fangtao Zhu, Mengdan Zhao, Yunfeng Yan · 2021 · International Journal of Pharmaceutics
  29. Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines
    Mohamed Attia, Ebtessam Ahmed Essa, Toka Tarek Elebyary, Ahmed Faheem, Amal Elkordy · 2021 · Pharmaceuticals
  30. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
    Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, Labiba Mustabina Oishee, Mutia Masuka Muna · 2022 · RNA Biology
  31. Structural and biochemical characteristics of mRNA nanoparticles determine anti–SARS-CoV-2 humoral and cellular immune responses
    Yingying Shi, Jiaxin Huang, Yu Liu, Jing Liu, Xuemeng Guo, Jianhua Li, Liming Gong, Xin Zhou, Guofeng Cheng, Yunqing Qiu et al. · 2022 · Science Advances
  32. In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA
    Ayoub Medjmedj, Albert Ngalle Loth, Rudy Clémençon, Josef Hamáček, Chantal Pichon, Federico Perche · 2022 · Nanomaterials
  33. Biomimetic Mineralized CRISPR/Cas RNA Nanoparticles for Efficient Tumor-Specific Multiplex Gene Editing
    Yan Liang, Jingge Zhang, Chenlu Xu, Jinjin Wang, Wenshuai Han, Jiali Yang, Sixuan Wu, Jingyi An, Junjie Liu, Zhenzhong Zhang et al. · 2023 · ACS Nano
  34. Edible Plant-Derived Extracellular Vesicles for Oral mRNA Vaccine Delivery
    Chiara Gai, Margherita Alba Carlotta Pomatto, Maria Chiara Deregibus, Marco Dieci, Alessandro Piga, Giovanni Camussi · 2024 · Vaccines
  35. Overview on LNP-mRNA encapsulation unit operation: Mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics
    Laurine Hourdel, Noureddine Lebaz, Florent Peral, Manon Ripoll, Stéphanie Briançon, Fethi Bensaid, Sumit Luthra, Claudia Cogné · 2025 · International Journal of Pharmaceutics
  36. Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
    Meiyu Wang, Li Zhang, Qianqian Li, Bo Wang, Ziteng Liang, Yeqing Sun, Jianhui Nie, Jiajing Wu, Xiao‐Dong Su, Xiaowang Qu et al. · 2021 · Emerging Microbes & Infections
  37. The Distinct Properties of Polysaccharide Nanoparticles Tune Immune Responses against mRNA Antigen via Stimulator of Interferon Genes-Mediated Autophagy and Inflammasome
    Yue Wu, Xiaoyu Liang, Canquan Mao, Yuhong Jiang · 2023 · ACS Nano
  38. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
    Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, Seyedeh Habibeh Mirmajidi, Iman Zare, Yasaman Naeimzadeh, Atena Mansouri, Amir Tajbakhsh, Amir Savardashtaki, Amirhossein Sahebkar · 2024 · Journal of Nanobiotechnology
  39. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates
    Labanya Mukhopadhyay, Pragya Dhruv Yadav, Nivedita Gupta, Sreelekshmy Mohandas, Deepak Y. Patil, Anita Shete-Aich, Samiran Panda, Balram Bhargava · 2021 · The Indian Journal of Medical Research
  40. A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response
    Duško Lainšček, Tina Fink, Vida Forstnerič, Iva Hafner‐Bratkovič, Sara Orehek, Žiga Strmšek, Mateja Manček‐Keber, Peter Pečan, Hana Esih, Špela Malenšek et al. · 2021 · Vaccines
  41. A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
    Paul E. Harris, Trevor Brasel, Christopher Massey, C.v. Herst, Scott Burkholz, Peter M. Lloyd, Tikoes Blankenberg, Thomas M. Bey, Richard T. Carback, Thomas W Hodge et al. · 2021 · Vaccines
  42. Effect of lipid composition on RNA-Lipid nanoparticle properties and their sensitivity to thin-film freezing and drying
    Khaled AboulFotouh, Benjamin Southard, Huy Minh Dao, Haiyue Xu, Chaeho Moon, Robert O. Williams, Zhengrong Cui · 2023 · International Journal of Pharmaceutics
  43. Identification of the metaphyseal skeletal stem cell building trabecular bone
    Guan Yang, Qi He, Xiaoxiao Guo, Rongyu Li, Jingting Lin, Wanyu Tao, Wenjia Liu, Wenjia Liu, Mingchuan Tang, Shilai Xing et al. · 2024 · Science Advances
  44. Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque
    Alireza Naderi Sohi, Jafar Kiani, Ehsan Arefian, Arezou Khosrojerdi, Zahra Fekrirad, Shokoofeh Ghaemi, Mohammad Kazem Zim, Arsalan Jalili, Nazila Bostanshirin, Masoud Soleimani · 2021 · Vaccines
  45. Animal models for SARS‐CoV‐2 infection and pathology
    Zhen-Fei Bi, Wei-Qi Hong, Jing-Yun Yang, Shuai-Yao Lu, Xiao-Zhong Peng · 2021 · MedComm
  46. Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice
    Eakachai Prompetchara, Chutitorn Ketloy, Mohamad‐Gabriel Alameh, Kittipan Tharakhet, Papatsara Kaewpang, Nongnaphat Yostrerat, Patrawadee Pitakpolrat, Supranee Buranapraditkun, Suwimon Manopwisedjaroen, Arunee Thitithanyanont et al. · 2023 · Nature Communications
  47. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice
    Heng Xia, Yun-Ru He, Xiao-Yong Zhan, Gao‐Feng Zha · 2023 · Antiviral Research
  48. Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
    Haitao Liu, Chenliang Zhou, Jiao An, Yujiao Song, Pin Yü, Jiadai Li, Chenjian Gu, Dongdong Hu, Yuanxiang Jiang, Lingli Zhang et al. · 2021 · Vaccine
  49. Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines
    Azam Bolhassani · 2022 · Molecular Biotechnology
  50. Efficient delivery of VEGFA mRNA for promoting wound healing via ionizable lipid nanoparticles
    Shuo Dong, Ji Wang, Zongke Guo, Yanhao Zhang, Wenhui Zha, Yang Wang, Chao Liu, Hanlei Xing, Xinsong Li · 2022 · Bioorganic & Medicinal Chemistry
  51. Novel Vectors and Administrations for mRNA Delivery
    Chenghai Bai, Chen Wang, Yuan Lu · 2023 · Small
  52. Effectiveness of COVID‑19 vaccines and their challenges (Review)
    Gabriella Marfè, Stefania Perna, Arvind Kumar Shukla · 2021 · Experimental and Therapeutic Medicine
  53. Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
    Hyunjoon Kim, Ameya R. Kirtane, Na Yoon Kim, Netra Unni Rajesh, Chaoyang Tang, Keiko Ishida, Alison M. Hayward, Róbert Langer, Giovanni Traverso · 2023 · The AAPS Journal
  54. Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
    Fangbin Zhou, Dongmei Zhang · 2023 · Frontiers in Immunology
  55. SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects
    Shiqin Li, Sijia Li, Cyrollah Disoma, Rong Zheng, Mei Ling Zhou, Aroona Razzaq, Pinjia Liu, Yuzheng Zhou, Zijun Dong, Ashuai Du et al. · 2020 · Reviews in Medical Virology
  56. In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
    Adnan Çetin · 2021 · Chemical Physics Letters
  57. A Comprehensive Overview on the Production of Vaccines in Plant-Based Expression Systems and the Scope of Plant Biotechnology to Combat against SARS-CoV-2 Virus Pandemics
    Manu Kumar, Nisha Kumari, Nishant Thakur, Shashi Kant Bhatia, Ganesh Dattatraya Saratale, Gajanan Sampatrao Ghodake, Bhupendra M. Mistry, Hemasundar Alavilli, D. S. Kishor, Xueshi Du et al. · 2021 · Plants
  58. RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
    Qingtai Liang, Yifeng Wang, Shuyuan Zhang, Jing Sun, Wenbo Sun, Jizhou Li, Yaping Liu, Mingxi Li, Lin Cheng, Yuhang Jiang et al. · 2022 · iScience
  59. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
    Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, Aryan Aarabi, Zahra Payandeh, Masoumeh Rajabibazl · 2022 · Cellular & Molecular Biology Letters
  60. A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice
    Shimeng Bai, Tianhan Yang, Cuisong Zhu, Meiqi Feng, Li Zhang, Ziling Zhang, Xiang Wang, Rui Yu, Xinghao Pan, Zhao Chen et al. · 2023 · Frontiers in Immunology
  61. Current progress and challenges in the design and development of a successful COVID-19 vaccine
    Tingting Li, Tianying Zhang, Ying Gu, Shaowei Li, Ningshao Xia · 2021 · Fundamental Research
  62. Opportunities for innovation: Building on the success of lipid nanoparticle vaccines
    Jessica Y. Huang, Daniel Yuen, Justine D. Mintern, Angus P. R. Johnston · 2021 · Current Opinion in Colloid & Interface Science
  63. Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
    Yang Wang, Huaicheng Tan, Ting Yu · 2021 · Frontiers in Immunology
  64. Nanoparticles and Antiviral Vaccines
    Sen Liu, Meilin Hu, Xiaoqing Liu, Xingyu Liu, Tao Chen, Yiqiang Zhu, Taizhen Liang, Shiqi Xiao, Peiwen Li, Xiancai Ma · 2023 · Vaccines
  65. Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice
    Zhenfei Bi, Weiqi Hong, Haiying Que, Cai He, Wenyan Ren, Jingyun Yang, Tianqi Lu, Li Chen, Shuaiyao Lu, Xiaozhong Peng et al. · 2021 · Signal Transduction and Targeted Therapy
  66. Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19)
    Roghayyeh Baghban, Abdolmajid Ghasemian, Shirin Mahmoodi · 2023 · Archives of Microbiology
  67. Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells
    Cristina Poveda, Ana Carolina Leão, Chiara Mancino, Francesca Taraballi, Yilin Chen, Rakesh Adhikari, María José Villar, Rakhi Tyagi Kundu, Duc Minh Nguyen, Leroy Versteeg et al. · 2023 · Current Research in Immunology
  68. A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs
    Jiawu Wan, Jianmei Yang, Zongmei Wang, Ruizhong Shen, Chengguang Zhang, Yuntao Wu, Ming Zhou, Huanchun Chen, Zhen Fang Fu, Haiwei Sun et al. · 2023 · Emerging Microbes & Infections
  69. Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
    Roya Ramezankhani, Roya Solhi, Arash Memarnejadian, Fatemeharefeh Nami, Seyed Mohammad Reza Hashemian, Tine Tricot, Massoud Vosough, Catherine M. Verfaillie · 2020 · International Journal of Antimicrobial Agents
  70. Nucleoside‐modified messenger RNA COVID‐19 vaccine platform
    Luca Roncati, Lorenzo Corsi · 2021 · Journal of Medical Virology
  71. Evidence of the presence of SARS‐CoV‐2 virus in atmospheric air and surfaces of a dedicated COVID hospital
    Abhishek Dubey, Garima Kotnala, Tuhin Kumar Mandal, Subash Chandra Sonkar, Vijay Kumar Singh, Sameer Ahmad Guru, Aastha Bansal, Monica Irungbam, Farah Husain, Binita Goswami et al. · 2021 · Journal of Medical Virology
  72. Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates
    Yixin Wu, Huicong Zhang, Liuxian Meng, Fusheng Li, Changyuan Yu · 2022 · Frontiers in Immunology
  73. Potential 3‐chymotrypsin‐like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID‐19 vaccine and drug development
    Shaomin Yan, Guang Ming Wu · 2021 · The FASEB Journal
  74. Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
    Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, Rohit Verma, Sandeep Goswami, Preeti Vishwakarma, Kamini Jakhar, Sudipta Sonar, Shailendra Mani, Sankar Bhattacharyya et al. · 2021 · Frontiers in Immunology
  75. COVID-19 Vaccine Platforms: Challenges and Safety Contemplations
    Hadeel T. Al-Jighefee, Hoda Najjar, Muna Nizar Ahmed, Abeer Qush, Sara Awwad, Layla Kamareddine · 2021 · Vaccines
  76. Advances in mRNA vaccines
    Mengyun Li, Zining Wang, Chunyuan Xie, Xiaojun Xia · 2022 · International review of cytology
  77. A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates
    Qing Ye, Dong Zhang, Rongrong Zhang et al. · 2024 · Nature Communications
  78. Freeze-Drying of mRNA-LNPs Vaccines: A Review
    MD Faizul Hussain Khan, Floriane Baudin, Ayyappasamy Sudalaiyadum Perumal, Amine Kamen · 2025 · Vaccines
  79. Bulk Electroporation for Intracellular Delivery Directly Driven by Mechanical Stimulus
    Fan Liu, Ze Ping Yang, Rui Ray Yao · 2022 · ACS Nano
  80. Proteoid biodynamers for safe mRNA transfection via pH-responsive nanorods enabling endosomal escape
    Sangeun Lee, Sarah S. Nasr, Sari Rasheed, Yun Liu, Olga Hartwig, Cansu Kaya, Annette S. Boese, Marcus Koch, Jennifer E. Herrmann, Rolf Müller et al. · 2022 · Journal of Controlled Release
  81. Production of mRNA lipid nanoparticles using advanced crossflow micromixing
    Muattaz Hussain, Burcu Binici, Liam O’Connor, Yvonne Perrie · 2024 · Journal of Pharmacy and Pharmacology
  82. A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates
    Limin Yang, Deyu Tian, Jian-Bao Han, Wenhui Fan, Yuan Zhang, Yunlong Li, Wenqiang Sun, Yanqiu Wei, Xiaodong Tian, Dan-Dan Yu et al. · 2021 · The Innovation
  83. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19
    Kun Xu, Yaling An, Qunlong Li, Wei-Jing Huang, Yuxuan Han, Tianyi Zheng, Fang Fang, Hui Liu, Chuan-Yu Liu, Ping Gao et al. · 2021 · Emerging Microbes and Infections
  84. Intracellular Self‐Immolative Polyprodrug with Near‐Infrared Light Guided Accumulation and in Vivo Visualization of Drug Release
    Dong‐Bing Cheng, Xuehao Zhang, Si‐Yi Chen, Xiao‐Xue Xu, Hao Wang, Zeng‐Ying Qiao · 2021 · Advanced Materials
  85. Progress and challenges of mRNA vaccines
    Liangru Lin, Yusheng Pei, Zhou Li, Dan Luo · 2022 · Interdisciplinary medicine
  86. Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, Sara M. Alwarthan, Mashael M. Alhajri, Mustafa A. Najim, Bashayer Mohammed Alshehail, Wasl Al-Adsani, Ali Alghadeer, Wesam A. Abduljabbar et al. · 2023 · Medicina
  87. Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates
    Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, Selma Zargari, Farzaneh Lal Alizadeh, Mahyar Dorrigiv, Asghar Abdoli, Hossein Aminianfar, Mahdi Hatamipour, Javad Zarqi et al. · 2023 · Journal of Controlled Release
  88. Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques
    Li, Jianglong, Yu, Pengcheng, Liu, Qi, Xu, Long, Chen, Yan, Li, Yan, Zhang, Fan, Zhu, Wuyang, Peng, Yucai · 2024 · npj Vaccines
  89. Rational preparation and application of a mRNA delivery system with cytidinyl/cationic lipid
    Lei Li, Jinrong Long, Ye Sang, Xin Wang, Xinyang Zhou, Yufei Pan, Yiming Cao, Huiyuan Huang, Zhenjun Yang, Jing Yang et al. · 2021 · Journal of Controlled Release
  90. Advances in Engineering Circular RNA Vaccines
    Zhongyan Zhang, Yuanlei Fu, Xiaoli Ju, Furong Zhang, Peng Zhang, Meilin He · 2024 · Pathogens
  91. Efficient circularization of protein-encoding RNAs via a novel cis -splicing system
    Shao-Jun Qi, Huiming Wang, Guopeng Liu, Qianshan Qin, Peng Gao, Bo Ying · 2024 · Nucleic Acids Research
  92. Nanomedicine Reimagined: Translational Strategies for Precision Tumor Theranostics
    Qinghe Wu, Xiaotong Yao, Xurui Duan, Xiaoyuan Shawn Chen, Jingjing Zhang · 2025 · Advanced Materials
  93. COVID-19 Vaccine in the Kingdom of Saudi Arabia
    Mazin Adnan Barry, Ahmed Salem BaHammam · 2021 · Journal of Nature and Science of Medicine
  94. SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications
    Lunzhi Yuan, Qiyi Tang, Huachen Zhu, Yi Guan, Tong Cheng, Ningshao Xia · 2021 · Emerging Microbes & Infections
  95. Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
    John S. Schardt, Ghasidit Pornnoppadol, Alec A. Desai, Kyung Soo Park, Jennifer M. Zupancic, Emily K. Makowski, Matthew D. Smith, Hongwei Chen, Mayara Garcia de Mattos Barbosa, Marília Cascalho et al. · 2021 · Scientific Reports
  96. Exosomal and Non-Exosomal MicroRNAs: New Kids on the Block for Cancer Therapy
    Shahzad Nawaz Syed, Bernhard Brüne · 2022 · International Journal of Molecular Sciences
  97. mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2
    Yuxuan Han, Yaling An, Qian Chen, Kun Xu, Xueyuan Liu, Senyu Xu, Huixin Duan, Annette B. Vogel, Uğur Şahin, Qihui Wang et al. · 2022 · Cell Research
  98. An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants
    Lei Huang, Fanfan Zhao, Muye He, Yi Fang, Xiaoping Ma, Shuaiyao Lu, Entao Li, Hui Qing Xiao, Hanfei Zhu, Xueli Wang et al. · 2024 · Journal of Controlled Release
  99. Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis
    Reem Matar, Christian Aloysius Than, Hayato Nakanishi, Rohan Suresh Daniel, Karen Smayra, Bernice L. Sim, Azizullah Beran, Omar A. Danoun · 2022 · Blood Coagulation & Fibrinolysis
  100. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations
    Bülent Kantarcıoğlu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Mark A. Ligocki, Walter P Jeske, Cafer Adıgüzel, Grigoris Gerotziafas et al. · 2022 · Clinical and Applied Thrombosis/Hemostasis